Concepedia
Statistics
Publications
4
Citations
100
H-Index
Active since
2017
Affiliations
Massachusetts General Hospital(Current)
University Medical Center Utrecht
Utrecht University
Farah R. W. Kools is an author at Massachusetts General Hospital specializing in medicine, pathology, and tumor biology.
Top concepts
MedicineArtsHealthOncologyPathologyJournalismCell BiologyPharmacologyMedia StudiesSocial Impact
Publications per year
2017–2018
Lysyl oxidase‐like 2 is a regulator of angiogenesis through modulation of endothelial‐to‐mesenchymal transition
Olivier G. de Jong, Lizet M. van der Waals, Farah R. W. Kools et al. · Journal of Cellular Physiology · 2018 · 40 citations · Full text
CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth
Patrick M. Reeves, Mojgan A. Abbaslou, Farah R. W. Kools et al. · Anti-Cancer Drugs · 2017 · 32 citations
Cxcr4 Blockade, Medicine, Tumor Growth +12
Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
Patrick M. Reeves, Mojgan A. Abbaslou, Farah R. W. Kools et al. · Oncotarget · 2017 · 15 citations · Full text
Publications Are Not the Finish Line: Focusing on Societal Rather Than Publication Impact
Farah R. W. Kools, Sara Mirali, Stephanie Holst et al. · Frontiers in Medicine · 2018 · 13 citations · Full text
Preclinical Therapeutics, Pharmacotherapy, Translational Advance +21
1–4 of 4